The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Regulatory News (COST)

Share Price Information for Costain (COST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 83.00
Bid: 83.00
Ask: 84.20
Change: 0.00 (0.00%)
Spread: 1.20 (1.446%)
Open: 83.60
High: 83.80
Low: 82.00
Prev. Close: 83.00
COST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading in line with strong cash performance

20 Jul 2022 07:00

RNS Number : 0937T
Costain Group PLC
20 July 2022
 

 

Costain Group PLC

20 July 2022

 

 

Trading in line with expectations with strong cash performance

 

 

Costain announces a trading update for the six months ended 30 June 2022, ahead of its interim results scheduled for 24 August 2022.

 

Operating performance: strong delivery and inflation resilience

 

The Group has delivered a good performance in the first half, with revenue ahead of market expectations1, reflecting the inflation recovery mechanisms built into contracts as we passed through increased costs with higher prices, together with increased volumes delivering revenue growth in Transportation and Natural Resources. We expect revenue for the full year to be ahead of market expectations.

 

Adjusted operating profit for the first half of 2022 is in line with management's expectations, with absolute profitability increasing year-on-year. We expect first half 2022 adjusted operating margin to be flat year-on-year, reflecting the continuing progress in the business offsetting inflation impacts. Supply chain pressures have been well managed ensuring a strong and robust operational performance across our contracts.

 

Our expectations for full year 2022 reported and adjusted operating profit are unchanged and we continue to expect good growth year-on-year.

 

Cash performance: ahead of expectations

 

Cash performance in the first half has been strong, driven by efficient working capital management and operating performance. Net cash at 30 June 2022 is around £95m, ahead of market expectations and we expect to deliver further positive net cash during the second half of the year.

 

Market performance: delivering against strategy

 

The Group's four chosen markets of Transport, Water, Energy and Defence continue to offer growth opportunities.

 

Transportation continues to operate well across our HS2, other Rail and Highway activities with a high volume of tender activity for further road and rail programmes, and aviation frameworks. In the period we have secured contracts including the first phase of the Lancaster South scheme and the TfL Piccadilly line design, and we are delivering growth on our Highways RDP programme.

Water performance is stable with good visibility across our five-year water AMP7 programmes for Anglian Water, Severn Trent Water, Southern Water, Thames Water and United Utilities, while Tideway continues to perform to plan.

Energy has shown good revenue growth in our design and programme management consultancy activities, building our position in energy transition, with wins including the bp net zero contract at Teesside and our first framework appointment by Shell. Our contracts with Cadent, EDF and Sellafield continue to perform strongly.

Defence includes key programme management contracts for our clients such as AWE and Babcock at Devonport, and is delivering increased revenue growth across our current defence portfolio.

 

Alex Vaughan, Chief Executive Officer, commented: "I am pleased with our performance in the first half of the year as we continue to generate strong free cash flow, deliver against our strategy and meet our customers' needs across our four markets. Our continued progress, supported by a strong order book and pipeline, gives us confidence for the remainder of the year and beyond."

 

 (1) First half market expectations are based on research from Investec, Liberum, Numis Securities and Peel Hunt.

 

Enquiries

 

Investors and analysts

Louise Bryant, Costain +44 7813 210 809

 

Financial media - Headland costain@headlandconsultancy.com

Andy Rivett-Carnac +44 7968 997 365

 

 

Notes to editors

 

Costain helps to improve people's lives by creating connected, sustainable infrastructure that enables people and the planet thrive. We shape, create and deliver pioneering solutions that transform the performance of the infrastructure ecosystem across the UK's transport, energy, water, and defence markets.

 

We are organised around our customers anticipating and solving their challenges and helping to improve performance. By bringing together our unique mix of construction, consulting and digital experts we engineer and deliver sustainable, efficient and practical solutions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKKBDQBKKBOB
Date   Source Headline
29th Nov 20162:42 pmRNSProposed Placing
21st Nov 20167:00 amRNSContract
15th Nov 20167:00 amRNSContract
4th Nov 20161:48 pmRNSDirector/PDMR Shareholding
1st Nov 20169:37 amRNSTotal Voting Rights
31st Oct 20167:00 amRNSTotal Voting Rights
27th Oct 20167:00 amRNSBlock Listing Application
19th Oct 20164:36 pmRNSDividend Declaration - Amendment
18th Oct 20168:00 amRNSDividend - Scrip Alternative
27th Sep 201612:38 pmRNSDirector/PDMR Shareholding
23rd Sep 201611:06 amRNSHolding(s) in Company
22nd Sep 201611:43 amRNSScrip Dividend Reference Price
20th Sep 201612:57 pmRNSHolding(s) in Company
6th Sep 201612:11 pmRNSDirector/PDMR Shareholding
1st Sep 201612:13 pmRNSHolding(s) in Company
30th Aug 20164:28 pmRNSHolding(s) in Company
30th Aug 20164:08 pmRNSHolding(s) in Company
24th Aug 20167:00 amRNSHalf-year Report
11th Jul 201610:16 amRNSDirector Declaration
6th Jul 20167:00 amRNSAcquisition
30th Jun 201612:53 pmRNSDirector/PDMR Shareholding
30th Jun 20168:57 amRNSBlock listing Interim Review
30th Jun 20167:00 amRNSTrading Update
17th Jun 20167:00 amRNSBusiness Briefing
31st May 20169:00 amRNSTotal Voting Rights
17th May 20167:00 amRNSDividend - Scrip Alternative
16th May 20163:03 pmRNSDirector/PDMR Shareholding
5th May 20164:51 pmRNSResult of AGM
5th May 20167:01 amRNSLTIP Listing Application
5th May 20167:00 amRNSAGM Statement
25th Apr 20167:00 amRNSHolding(s) in Company
21st Apr 20162:05 pmRNSScrip Dividend Reference Price
18th Apr 201610:22 amRNSHolding(s) in Company
7th Apr 20167:00 amRNSDirector/PDMR Shareholding
6th Apr 20167:00 amRNSAppointment of Chairman Designate
4th Apr 201610:38 amRNSDirector/PDMR Shareholding
31st Mar 201610:32 amRNSNotice of AGM
2nd Mar 20167:00 amRNSFinal Results
1st Feb 20167:00 amRNSRe Contract
21st Jan 20169:07 amRNSHolding(s) in Company
11th Jan 20167:00 amRNSConfirmation of Contract Award
7th Jan 201612:17 pmRNSHolding(s) in Company
6th Jan 20167:00 amRNSTrading Update
4th Jan 20168:55 amRNSBlocklisting Interim Review
24th Dec 201512:17 pmRNSDirector/PDMR Shareholding
22nd Dec 201511:46 amRNSHolding(s) in Company
22nd Dec 20159:13 amRNSHolding(s) in Company
17th Dec 20157:00 amRNSRe Contract
9th Dec 201511:22 amRNSHolding(s) in Company
1st Dec 20159:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.